GLPwatch
Trials (2167)
Page 19 of 37.
- Transition From Basal/Bolus to Once-weekly Subcutaneous Semaglutide and Basal Insulin in Patients With T2D
- Extension of ALT-801 in Diabetic and Non-Diabetic Overweight and Obese Subjects With (NAFLD)
- A Comparison of Two Treatment Strategies in Older Participants With Type 2 Diabetes Mellitus (T2DM)
- The Effect of Adherence to Oral Semaglutide on Glycaemic Control in People With Type 2 Diabetes Treated With Metformin
- Semaglutide's Effect on Renal Hemodynamics and Function in Patients With Type 2 Diabetes Mellitus and Nephropathy
- IMPACT-MACS: Adrenalectomy vs Semaglutide for Metabolic Outcomes in Mild Autonomous Cortisol Secretion
- GLP-1 Receptor Agonist Lixisenatide Versus Exenatide in Patients With Type 2 Diabetes for Glycemic Control and Safety Evaluation, on Top of Metformin
- A Study to Evaluate the Safety and Efficacy of NG101 in Adult Participants Receiving a Glucagon-like Peptide-1 (GLP-1) Agonist
- A Study Investigating Oral Semaglutide in People with Open-Angle Glaucoma
- Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Multiple Subcutaneous Injections of HRS9531 in Patients With Type 2 Diabetes Mellitus
- The Efficacy, Mechanism & Safety of Sodium Glucose Co-Transporter-2 Inhibitor & Glucagon-Like Peptide 1 Receptor Agonist Combination Therapy in Kidney Transplant Recipients
- Impact GLP-1 Agonists Following Bariatric
- Liraglutide Effectiveness in Preoperative Weight-loss for Bariatric-metabolic Surgery
- Impact of GLP-1 Receptor Agonists on Dry Eye Disease in Patients With Type 2 Diabetes Mellitus and Obesity
- Effect of AC2993 Compared With Insulin Glargine in Patients With Type 2 Diabetes Also Using Combination Therapy With Sulfonylurea and Metformin
- Epicardial Adipose Tissue Composition and Heart Failure With Preserved Ejection Fraction
- A Research Study Looking at How Semaglutide Works in People With Type 2 Diabetes in Denmark and Sweden, as Part of Local Clinical Practice (SURE DENMARK/SWEDEN)
- Combination of Biologic and Anti-obesity Therapies in Psoriatic Arthritis
- Efficacy of Mazdutide for Treating PCOS
- A Study to See the Effect of NNC0194-0499 Alone or in Combination With Semaglutide on Blood Sugar Control in People Living With Type 1 Diabetes
- Durability of Combination of Insulin and GLP-1 Receptor Agonist or SGLT-2 Inhibitors Versus Basal Bolus Insulin Regimen in Type 2 Diabetes (BEYOND)
- A Pilot Study of the Effects on Sleep Disordered Breathing (SDB) When Using the Drug Liraglutide for 4 Weeks
- A PK/PD Study of Polyethylene Glycol Loxenatide in Patients With Type 2 Diabetes
- A Study of IBI362 in Chinese Adolescents With Obesity or Overweight
- Risk Factors Affect Weight Loss Outcomes After Treatment.
- IMPACT TRIAL: Efficacy and Safety of Pemvidutide in Subjects With Nonalcoholic Steatohepatitis (NASH)
- Tirzepatide in the Treatment of Cannabis Use Disorder
- A Study of Tirzepatide (LY3298176) in Participants With Overweight or Obesity and Chronic Kidney Disease With or Without Type 2 Diabetes
- A Study of LY3437943 in Japanese Participants With Type 2 Diabetes Mellitus (T2DM)
- Liraglutide in Obesity and Diabetes: Identification of CNS Targets Using fMRI
- Mazdutide for Remission of Type 2 Diabetes: Multicentre, Double Blind, Randomised, Placebo Controlled Trial
- Smoking Cessation Facilitated by Glucagon-like Peptide-1 (GLP-1) Analogues
- A Proof-of-Concept Study to Evaluate Topical-Lingual Semaglutide in Adults With Obesity
- Specific Clinical Experience Investigation for Long-term Use of Bydureon.
- A Study Comparing the Effects and Safety of Dulaglutide With Insulin Glargine in Type 2 Diabetes Mellitus
- A Study to Investigate Safety and Efficacy of iGlarLixi in Adult Patients With Type 2 Diabetes Mellitus
- Impact of Pharmacogenetic-Guided Treatment on Type 2 Diabetes.
- Effect of Retatrutide Compared With Placebo in Participants With Type 2 Diabetes and Moderate or Severe Renal Impairment, With Inadequate Glycemic Control on Basal Insulin, With or Without Metformin and/or SGLT2 Inhibitor (TRANSCEND-T2D-3)
- The Effect of GLP-1 Agonist in Patients With Hypothalamic Obesity: Prospective, Pilot Study
- Tirzepatide for Alcohol Use Disorder
- A Study to Investigate Effectiveness of Tirzepatide Following Initiation of Ixekizumab in Participants With Active Psoriatic Arthritis and Overweight or Obesity in Clinical Practice (TOGETHER AMPLIFY-PsA)
- A Trial Investigating the Influence of Oral Semaglutide on the Pharmacokinetics of Levothyroxine and the Influence of Co-administered Tablets on the Pharmacokinetics of Semaglutide Administered Orally in Healthy Subjects.
- A Clinical Trial to Evaluate The Effects of Semaglutide and Empagliflozin Combined to Automated Insulin Delivery on Diabetes Control in Adults Living With Type 1 Diabetes
- A Pan-European Post-Authorisation Safety Study: Risk of Pancreatic Cancer Among Type 2 Diabetes Patients Who Initiated Exenatide as Compared With Those Who Initiated Other Non-Glucagon-Like Peptide 1 Receptor Agonists Based Glucose Lowering Drugs
- Study That Tests AD109 in Patients Taking GLP-1 Drugs
- A Research Study Looking at Similarity Between Once-weekly Semaglutide Versions for Different Injection Pens
- Effects of Incretin on the Blood Pressure and Lipid in Patients With Overweight or Obese Diabetes
- Glucagon Like Peptide 1 Receptor (GLP1R) Expression and Beta-cell Mass in Patients With Type 2 Diabetes
- Glucose-dependent INsulinotropic Polypeptide: Effect on Bone Remodelling and Cell Activity (GINEBRA)
- Safety and Efficacy of YH14617 in Diabetes Mellitus
- Genetic, Microbiological and Behavioral Factors in Obesity
- Response to Semaglutide in Non-diabetic Obese Patients With Varying Degrees of Insulin Resistance
- A Research Study to See How Well CagriSema Helps People in East Asia With Excess Body Weight Lose Weight
- Comparison of the Efficacy and Safety of Insulin Glargine/Lixisenatide Fixed Ratio Combination to Insulin Glargine in Patients With Type 2 Diabetes Insufficiently Controlled on Basal Insulin
- Exercise and Diabetes Interventions to Improve Brain Health in Older Adults With Type 2 Diabetes
- Effect of Liraglutide for Weight Management in Pubertal Adolescent Subjects With Obesity
- Holding vs. Continuing Incretin-based Therapies Before Upper Endoscopy
- Direct Measurement of Microstructure of Ingestive Behaviour After Initiation of GLP-1 Receptor Agonist Treatment at Maximum Dose (DIGRAT)
- Effects of GLP-1 on Chronic Heart Failure
- Efficacy and Safety of Semaglutide Versus Canagliflozin as add-on to Metformin in Subjects With Type 2 Diabetes